Legal Representation
Attorney
Maurine Knutsson
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-04-30)
Due Date
April 30, 2025
Grace Period Ends
October 30, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
38 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 17, 2025 | C75P | O | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. |
| Jun 17, 2025 | NA75 | E | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED |
| Jun 16, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Mar 7, 2025 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
| Feb 25, 2025 | ES75 | I | TEAS SECTION 71 & 15 RECEIVED |
| Jun 5, 2020 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| Apr 15, 2020 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| Apr 2, 2020 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Sep 13, 2019 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Aug 26, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED |
| Aug 26, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
| Aug 15, 2019 | PLGL | A | ASSIGNED TO PARALEGAL |
| Aug 15, 2019 | LIME | I | LIMITATION FROM THE IB EXAMINED AND ENTERED |
| Aug 15, 2019 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED |
| Jul 30, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Apr 30, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Feb 12, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 8, 2019 | GPNX | P | NOTIFICATION PROCESSED BY IB |
| Feb 1, 2019 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB |
| Jan 23, 2019 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Jan 23, 2019 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Jan 23, 2019 | NPUB | O | NOTICE OF PUBLICATION |
| Jan 3, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Dec 29, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Dec 28, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Dec 28, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Nov 9, 2018 | RFNT | P | REFUSAL PROCESSED BY IB |
| Oct 23, 2018 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Oct 23, 2018 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Oct 12, 2018 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Oct 11, 2018 | RFWR | P | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Oct 11, 2018 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Oct 11, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 10, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Oct 9, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Oct 3, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 3, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Sep 27, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Detailed Classifications
Class 001
Substances for use in cell-based reporter gene assays, namely, assays for research purposes; reagents for medical research purposes; reagents for research purposes; reagents for industrial purposes, namely, reagents for scientific and research use; reagents for chemical analyses, namely, chemical reagents for non-medical purposes; cells and reagents for scientific and research use in testing of pharmaceutical products; cell culture media for scientific and research use, namely, cell-lines; components for cell-based analyses using optical methods and containing chemical reagents, namely, cells for scientific and research use; chemical preparations for the laboratory and for scientific, diagnostic and analytical purposes, other than for medical or veterinary use
Class 005
Reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; diagnostic and analytical substances for medical and veterinary purposes, in particular, laboratory diagnostic kits comprised of medical diagnostic reagents, anti-bodies, and immunochemicals for use in disease detection in the area of medical prevention
Class 009
[ Instruments for use in performing cell-based assays by means of optic detection, namely, optical inspection apparatus; computer software for use in performing optic based biological analysis; computer software for use in performing optic based biological analysis, and for using tools during drug development, clinical diagnosis, clinical monitoring or assay development; computer application software for mobile phones and handheld computers, namely, software for patient monitoring; apparatus for recording, transmission and reproduction of sound and images; blank magnetic data carriers; digital recording media, namely, blank digital storage media ]
Class 042
Cell-based assay services, namely, custom design and development of cell-based biochemical assays; cell-based assay services, namely, custom design and development of cell-based biochemical assays for use in drug development, clinical diagnosis, clinical monitoring or assay development; medical research; clinical research in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific research; research and development in the field of diagnostic preparations; pharmaceutical drug development services; [ conducting clinical trials for others; ] laboratory research and analysis services in the field of drug development, clinical diagnosis, clinical monitoring or assay development; scientific laboratory testing services; [ research in the fields of medicine and data analytics; ] providing scientific diagnostic services for others in the fields of drug development, clinical diagnosis, clinical monitoring or assay development [ ; testing of chemical preparations and cells for diagnostic purposes ]
Class 044
Medical testing services relating to measurement and quantification of drug levels and immunogenicity in patient samples for diagnostic or treatment purposes [ ; medical services, namely, treating persons based on laboratory analysis; providing medical support in the nature of medical monitoring of patients receiving medical treatments; medical diagnostic testing services ]
Additional Information
Color Claim
Color is not claimed as a feature of the mark.
Translation
The English translation of the word "SVAR" in the mark is "ANSWER".
Other
In the heading and in the statement class 9 is cancelled in accordance with the F-note dated 8/15/19.
Classification
International Classes
001
005
009
042
044
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO